from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2614c/thrS

LFCtreatmentdescriptionclass of inhibitor

-1.481

Amikacinug/mL Amikacintranslation

-0.894

Cap5-10ug/mL Capreomycintranslation

-1.417

Rox10-50 ug/mL Roxithromycintranslation

-1.045

SM2-5 ug/mL Streptomycintranslation

-2.823

Tet5-10 ug/mL Tetracyclinetranslation

0.095

Rif0.2-5ug/mL Rifampicintranscription

-0.284

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.537

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.005

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.175

CPZ10-50 ug/mL Chlorpromazinerespiration

0.890

Clofazimine10-13 ug/mL Clofaziminerespiration

0.437

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.750

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.034

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.478

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.591

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.068

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.096

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.218

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.314

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.894

KCN5-20 ug/mL Potassium cyaniderespiration

0.378

NaN30.2-2 mM Sodium aziderespiration

-1.152

Nigericin50 uM Nigericinrespiration

-0.083

TRC10-150 ug/mL Triclosanrespiration

1.239

TRZ10-25 ug/mL Thioridazinerespiration

-1.111

Valinomycin0.5-10 uM Valinomycinrespiration

-0.542

ZnSO42 mM ZnSO4respiration

-0.297

menadione6-10 ug/mL Menadionerespiration

0.039

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.316

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.197

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.926

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.575

NRP_1Non-replicating persistence stage 1dosRassociated

-0.666

Amp0.2mg/mL AmpicillincellWall

0.162

Cephalexin20-100 ug/mL CephalexincellWall

-0.001

Cerulenin0.32-5 ug/mL CerulenincellWall

0.106

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.040

EMB10-20 ug/mL EthambutolcellWall

-1.011

Eta12-40 ug/mL EthionamidecellWall

-1.579

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.650

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.518

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.205

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.034

BZA0.12 mg/mL BenzamidearomaticAmides

0.393

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.070

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.103

H2O24 mM hydrogen peroxideDNAdamaging

0.164

Levo10 ug/mL LevofloxacinDNAdamaging

0.159

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.206

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.148

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.511

UVUV-irradiationDNAdamaging

0.577

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.361

Antimycin12.5-50 ug/mL Antimycin A?

-0.530

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.573

PA_110-50 ug/mL Antitubercular compound PA-1?

0.156

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.377

PA8240.2-2 ug/mL PA-824?

0.336

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.148

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.437

Verapamil50 uM Verapamil?

0.151

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.073

methoxatin10-20 ug/mL Methoxatin?